Related Experiment Video
Updated: May 9, 2026
Identifying Protein-protein Interaction Sites Using Peptide Arrays
Published on: November 18, 2014
Interaction studies to evaluate 2- carboxyphenolate analogues as inhibitor of anti-apoptotic protein Bcl-2
1Dean of Faculty of Health Sciences, Buraydah Colleges, Al-Qassim - Buraydah, P.O.Box 51418.
Abstract:
Apoptosis is a cellular process that leads to the death of damaged cells. Its malfunction can cause cancer and poor response to conventional chemotherapy. After being activated by cellular stress signals, pro-apoptotic proteins bind anti-apoptotic proteins, thus allowing apoptosis to go forward. An excess of anti-apoptotic proteins can prevent apoptosis. Designed molecules that imitate the roles of pro-apoptotic proteins can promote the death of cancer cells. In this work we have applied an insilico approach to study the binding of 2-carboxyphenolate analogues as potent inhibitors of anti-apoptotic protein Bcl-2. Molecular docking study was performed in order to find specific binding mode using AutoDock. From the docking results it was observed that zinc 2- carboxyphenolate showed strong inhibition with Bcl-2 with docking energy of -4.6 kcal/mol. The effects of the Zinc 2- hydroxybenzoate on apoptosis in HT-1080 cell lines were also analysed, which shows strong evidence for their apoptotic mode of action using flow cytometric analysis of Annexin-V. Our study gave valuable insights on inhibitor specificity of anti-apoptotic proteins and might be considered as potent chemopreventive agents.
Insights
Researchers explored 2-carboxyphenolate analogues as potential cancer treatments by inhibiting the anti-apoptotic protein Bcl-2. Zinc 2-carboxyphenolate demonstrated strong binding and induced apoptosis in cancer cells, suggesting chemopreventive potential.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Apoptosis, or programmed cell death, is crucial for eliminating damaged cells.
- Dysfunctional apoptosis is implicated in cancer development and resistance to chemotherapy.
- Anti-apoptotic proteins, like Bcl-2, can prevent cell death, promoting cancer cell survival.
Purpose of the Study:
- To investigate 2-carboxyphenolate analogues as inhibitors of the anti-apoptotic protein Bcl-2 using an in silico approach.
- To evaluate the potential of these compounds as chemopreventive agents by assessing their ability to induce apoptosis in cancer cells.
Main Methods:
- In silico molecular docking studies using AutoDock to analyze the binding of 2-carboxyphenolate analogues to Bcl-2.
- Flow cytometric analysis using Annexin-V to assess the apoptotic effects of Zinc 2-hydroxybenzoate on HT-1080 cell lines.
Main Results:
- Molecular docking revealed that zinc 2-carboxyphenolate strongly inhibits Bcl-2 with a docking energy of -4.6 kcal/mol.
- Experimental analysis confirmed that Zinc 2-hydroxybenzoate induces apoptosis in HT-1080 cancer cells, supporting its apoptotic mechanism of action.
Conclusions:
- 2-carboxyphenolate analogues, particularly zinc 2-carboxyphenolate, show significant potential as inhibitors of Bcl-2.
- These compounds may serve as effective chemopreventive agents by promoting cancer cell apoptosis.
